시장보고서
상품코드
1838445

생물제제 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 최종 사용자별, 프로세스별, 디바이스별, 재료 유형별, 전개별(-2034년)

Biologics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Device, Material Type, Deployment

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 393 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생물제제 시장은 2024년 5억 8,150만 달러로 평가되었고, 2034년에는 13억 2,320만 달러로 확대될 전망이며, 약 8.6%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다. 생물제제 시장에는 단백질, 핵산, 세포 등 생물 유래의 치료 제품이 포함됩니다. 이 생물제제은 암과 자가 면역 질환과 같은 만성질환의 치료에 매우 중요합니다. 생명 공학의 진보, 만성질환 증가, 맞춤형 의료에 대한 수요 증가가 시장을 견인하고 있습니다. 단일클론항체, 유전자 요법 및 바이오시밀러의 혁신은 치료 옵션을 넓히고 효능을 높입니다. 규제 당국의 지원과 전략적 제휴는 시장 성장을 더욱 강화하고 있으며, 생물제제는 현대 치료법의 핵심으로 자리매김하고 있습니다.

생물제제 시장은 바이오 기술과 맞춤형 의료의 진보에 견인되어 강력한 확장을 경험하고 있습니다. 단일클론항체 부문은 만성질환 및 암 치료에 있어서 그 효능에 의해 최상급의 하위 부문으로 부상하고 있습니다. 재조합 단백질은 치료 및 백신에 대한 용도 증가를 반영하여 약간의 차이로 계속됩니다. 유전자 치료는 유전 공학 및 표적 치료의 기술 혁신에 힘입어 큰 잠재력을 보여줍니다. 세포 요법은 줄기 세포 연구가 유망한 치료 성과를 가져오고 있으며, 기세를 늘리고 있습니다. 바이오시밀러 의약품은 브랜드 생물제제를 대체하는 비용 효율적인 대체품에 대한 요구를 배경으로 점점 더 중요해지고 있습니다. 이러한 추세는 보다 사용하기 쉬운 의료 솔루션으로의 전환을 촉진합니다. 시장은 또한 생물제제에 의한 치료의 효능과 환자의 컴플라이언스를 향상시키는 고급 약물 전달 시스템에 대한 수요의 급증을 목격하고 있습니다. 생물제제 기업 간 전략적 제휴와 공동 연구는 혁신을 촉진하고 새로운 생물제제 시장 개척을 가속화하고 있으며, 시장은 지속적인 성장과 유리한 기회를 향해 자리매김하고 있습니다.

시장 세분화
유형별 단일클론항체, 백신, 재조합 단백질, 유전자 치료, 세포 치료, 바이오시밀러, 혈액 제제, 효소
제품별 치료용 단백질, 항체 약물 복합체, 사이토카인, 융합 단백질, 성장 인자, 호르몬, 인터페론, 인터루킨
서비스별 위탁 연구, 수탁 제조, 임상시험, 레귤러토리 서비스, 품질 보증, 공급망 관리, 물류
기술별 DNA 시퀀싱, CRISPR, 합성 생물학, 바이오프로세스, 나노 기술, 단백질 엔지니어링, 바이오 프린팅
용도별 종양학, 감염, 자가면역 질환, 심혈관 질환, 대사성 질환, 신경학, 안과학, 피부과학
최종 사용자별 제약회사, 생명공학기업, 연구기관, 병원, 클리닉, 진단연구소, 학술기관
프로세스별 업스트림 공정, 다운스트림 공정, 제형화, 정제, 발효, 세포 배양
디바이스별 바이오리액터, 원심분리기, 크로마토그래피 시스템, 여과 시스템, 혼합 시스템
재료 유형별 단백질, 항체, 핵산, 세포, 바이러스 벡터
전개별 인하우스, 아웃소싱, 하이브리드

시장 현황

생물제제는 혁신적인 치료법과 확립된 치료법에 의해 큰 시장 점유율을 차지하며 의약품 업계를 지배하고 있습니다. 가격 전략은 생산의 복잡성과 임상 효능에 따라 다양합니다. 생명 공학의 진보와 모노클로날 항체, 백신 및 유전자 치료의 풍부한 파이프라인을 반영하여 신제품 출시는 자주 수행됩니다. 맞춤형 의료 및 표적 치료에 대한 수요 증가가 시장을 뒷받침하고 있습니다. 북미와 유럽이 주요 지역이지만 아시아태평양은 헬스케어 투자 증가 및 정부의 지원 정책에 따라 성장이 가속화되고 있습니다. 생물제제 시장의 경쟁은 치열하고, 주요 기업들은 경쟁력을 유지하기 위해 연구 개발에 많은 투자를 하고 있습니다. 규제의 영향은 매우 중요한 역할을 하고 있으며, 엄격한 승인 프로세스가 시장 진입과 확대에 영향을 미치고 있습니다. FDA와 EMA는 높은 기준을 세우고 안전성 및 효율성을 확보하고 있기 때문에 제품의 출시를 지연시킬 가능성은 있지만, 궁극적으로 시장의 신뢰성을 높일 것입니다. 신흥 시장에는 유리한 기회가 있지만, 다양한 규제 상황을 극복하기 위해서는 전략적 인사이트가 필요합니다. 생물제제의 미래는 유망하고, 세포 치료 및 유전자 치료의 진보가 혁신과 시장 발전를 촉진합니다.

주요 동향 및 성장 촉진요인 :

생물제제 시장은 생명공학의 진보와 맞춤형 의료에 대한 수요 증가에 힘입어 강력한 성장을 이루고 있습니다. 주요 동향으로는 단일클론항체나 세포 및 유전자 치료의 대두를 들 수 있으며, 이들은 다양한 질환의 치료 패러다임에 혁명을 가져오고 있습니다. 이러한 혁신은 질병 메커니즘과 인간 유전체에 대한 더 깊은 이해가 원동력이 되고 있습니다. 규제 당국의 지원과 신속한 승인 경로는 시장 확대를 더욱 가속화하고 있습니다. 각국 정부는 언메트 메디컬 니즈에 대응하는 생물제제의 가능성을 인식하고 승인 프로세스를 간소화하고 있습니다. 게다가 만성질환의 만연 및 인구의 고령화가 큰 추진력이 되고 있으며, 새로운 치료 솔루션이 필요합니다. 생물제제 업계에서는 연구개발에 많은 투자가 이루어지고 있습니다. 각 회사는 생산 능력 강화와 약물전달 시스템의 개선에 주력하고 있습니다. 헬스케어 인프라가 정비되고 있는 신흥 시장에는 비즈니스 기회가 넘치고 있습니다. 전략적 제휴와 파트너십은 기업이 보완적인 강점을 활용하고 세계적인 발자취를 확대할 수 있게 해주고 널리 사용되고 있습니다. 생물제제 시장은 지속적인 기술 혁신과 전략적 이니셔티브를 원동력으로 지속적으로 성장하는 태세가 갖추어져 있습니다.

성장 억제요인 및 과제 :

생물제제 시장은 현재 몇 가지 중요한 시장 성장 억제요인 및 과제에 직면하고 있습니다. 주요 과제 중 하나는 생물학적 제형의 가격이 높다는 것입니다. 이는 환자의 접근성을 제한하고 헬스케어 시스템에 재정적 부담을 강요하는 것입니다. 생물학적 제제의 제조 공정이 복잡하기 때문에 전문 시설과 숙련된 인재에 대한 많은 투자가 필요하며 이 문제를 더욱 악화시키고 있습니다. 또한 규제상의 장애물도 엄청난 과제입니다. 생물제제의 엄격한 승인 프로세스는 일정의 장기화 및 비용 증가로 이어져 중소기업 시장 진입을 막습니다. 지적 재산의 문제도 큰 장벽이 됩니다. 특허의 해지에 의해 바이오시밀러에 대한 길이 열리고, 경쟁이 격화해 시장 점유율에 영향이 미치기 때문입니다. 공급망의 혼란은 종종 지정학적 긴장과 세계 건강 위기로 인해 발생하며 생물제제의 부족과 유통 지연으로 이어질 수 있습니다. 마지막으로, 콜드체인 물류의 필요성은 복잡성과 비용을 더욱 증가시키고, 특히 저자원 환경에서 시장 확대를 방해합니다.

주요 기업

Sandoz, Samsung Biologics, Biocon, Catalent, WuXi Biologics, Lonza, Sartorius, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, Abzena, AGC Biologics, Samsung Bioepis, Cytiva, Bavarian Nordic, Morphosys

목차

제1장 생물제제 시장 개요

  • 조사 목적
  • 생물제제 시장 정의 및 조사 범위
  • 보고서의 한계
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 생물제제 시장 전망

  • 생물제제 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 생물제제 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 생물제제 시장 규모

  • 생물제제 시장 규모 : 금액별
  • 생물제제 시장 규모 : 수량별

제7장 생물제제 시장 : 유형별

  • 시장 개요
  • 단일클론항체
  • 백신
  • 재조합 단백질
  • 유전자 치료
  • 세포요법
  • 바이오시밀러
  • 혈액제제
  • 효소
  • 기타

제8장 생물제제 시장 : 제품별

  • 시장 개요
  • 치료용 단백질
  • 항체 약물 복합체
  • 사이토카인
  • 융합 단백질
  • 성장인자
  • 호르몬
  • 인터페론
  • 인터루킨
  • 기타

제9장 생물제제 시장 : 서비스별

  • 시장 개요
  • 수탁연구
  • 수탁 제조
  • 임상시험
  • 약사 서비스
  • 품질 보증
  • 공급망 관리
  • 물류
  • 기타

제10장 생물제제 시장 : 기술별

  • 시장 개요
  • DNA 시퀀싱
  • CRISPR
  • 합성 생물학
  • 바이오프로세스
  • 나노기술
  • 단백질 공학
  • 바이오프린팅
  • 기타

제11장 생물제제 시장 : 용도별

  • 시장 개요
  • 암 영역
  • 감염증
  • 자가면역질환
  • 심혈관 질환
  • 대사질환
  • 신경학
  • 안과
  • 피부과학
  • 기타

제12장 생물제제 시장 : 최종 사용자별

  • 시장 개요
  • 제약기업
  • 바이오테크놀러지 기업
  • 연구기관
  • 병원
  • 클리닉
  • 진단 실험실
  • 학술기관
  • 기타

제13장 생물제제 시장 : 프로세스별

  • 시장 개요
  • 업스트림 공정
  • 다운스트림 공정
  • 제제화
  • 정제
  • 발효
  • 세포 배양
  • 기타

제14장 생물제제 시장 : 디바이스별

  • 시장 개요
  • 바이오리액터
  • 원심분리기
  • 크로마토그래피 시스템
  • 여과 시스템
  • 혼합 시스템
  • 기타

제15장 생물제제 시장 : 재료 유형별

  • 시장 개요
  • 단백질
  • 항체
  • 핵산
  • 세포
  • 바이러스 벡터
  • 기타

제16장 생물제제 시장 : 전개별

  • 시장 개요
  • 인하우스
  • 아웃소싱
  • 하이브리드
  • 기타

제17장 생물제제 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제19장 기업 프로파일

  • Sandoz
  • Samsung Biologics
  • Biocon
  • Catalent
  • WuXi Biologics
  • Lonza
  • Sartorius
  • Boehringer Ingelheim
  • Fujifilm Diosynth Biotechnologies
  • Abzena
  • AGC Biologics
  • Samsung Bioepis
  • Cytiva
  • Bavarian Nordic
  • MorphoSys
AJY 25.11.05

Biologics Market is anticipated to expand from $581.5 million in 2024 to $1,323.2 million by 2034, growing at a CAGR of approximately 8.6%. The Biologics Market encompasses therapeutic products derived from living organisms, including proteins, nucleic acids, and cells. These biologics are pivotal in treating chronic diseases such as cancer and autoimmune disorders. The market is driven by advancements in biotechnology, increasing prevalence of chronic diseases, and rising demand for personalized medicine. Innovations in monoclonal antibodies, gene therapies, and biosimilars are expanding treatment options and enhancing efficacy. Regulatory support and strategic collaborations further propel market growth, positioning biologics as a cornerstone of modern therapeutics.

The Biologics Market is experiencing robust expansion, driven by advancements in biotechnology and personalized medicine. The monoclonal antibodies segment emerges as the top-performing sub-segment, owing to their efficacy in treating chronic diseases and cancer. Recombinant proteins follow closely, reflecting increased applications in therapeutic treatments and vaccines. Gene therapy showcases significant potential, propelled by innovations in genetic engineering and targeted treatments. The cell therapy sub-segment is gaining momentum, with stem cell research offering promising therapeutic outcomes. Biosimilars are becoming increasingly relevant, driven by the need for cost-effective alternatives to branded biologics. This trend is prompting a shift towards more accessible healthcare solutions. The market is also witnessing a surge in demand for advanced drug delivery systems, enhancing the efficacy and patient compliance of biologic treatments. Strategic partnerships and collaborations between biopharmaceutical companies are fostering innovation and accelerating the development of novel biologics, positioning the market for sustained growth and lucrative opportunities.

Market Segmentation
TypeMonoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy, Cell Therapy, Biosimilars, Blood Products, Enzymes
ProductTherapeutic Proteins, Antibody Drug Conjugates, Cytokines, Fusion Proteins, Growth Factors, Hormones, Interferons, Interleukins
ServicesContract Research, Contract Manufacturing, Clinical Trials, Regulatory Services, Quality Assurance, Supply Chain Management, Logistics
TechnologyDNA Sequencing, CRISPR, Synthetic Biology, Bioprocessing, Nanotechnology, Protein Engineering, Bioprinting
ApplicationOncology, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Disorders, Neurology, Ophthalmology, Dermatology
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Hospitals, Clinics, Diagnostic Labs, Academic Institutions
ProcessUpstream Processing, Downstream Processing, Formulation, Purification, Fermentation, Cell Culture
DeviceBioreactors, Centrifuges, Chromatography Systems, Filtration Systems, Mixing Systems
Material TypeProteins, Antibodies, Nucleic Acids, Cells, Viral Vectors
DeploymentIn-house, Outsourced, Hybrid

Market Snapshot:

Biologics continue to dominate the pharmaceutical landscape, with significant market share held by innovative therapies and established treatments. Pricing strategies vary, driven by the complexity of production and clinical efficacy. New product launches are frequent, reflecting advancements in biotechnology and a robust pipeline of monoclonal antibodies, vaccines, and gene therapies. The market is buoyed by increasing demand for personalized medicine and targeted therapies. North America and Europe are key regions, though Asia-Pacific is witnessing accelerated growth due to rising healthcare investments and supportive government policies. Competition in the biologics market is intense, with leading companies investing heavily in R&D to maintain their competitive edge. Regulatory influences play a pivotal role, with stringent approval processes impacting market entry and expansion. The FDA and EMA set high standards, ensuring safety and efficacy, which can delay product launches but ultimately enhance market credibility. Emerging markets offer lucrative opportunities, yet navigating diverse regulatory landscapes requires strategic acumen. Biologics' future is promising, with advancements in cell and gene therapies driving innovation and market evolution.

Geographical Overview:

The biologics market is witnessing robust growth across diverse regions, each presenting unique opportunities. North America retains a dominant position, bolstered by advanced healthcare infrastructure and significant R&D investments. The presence of leading biopharmaceutical firms further drives innovation and market expansion. Europe follows, with its strong emphasis on biotechnology research and favorable regulatory frameworks enhancing market dynamics. The Asia Pacific region is experiencing rapid market growth, driven by an increasing prevalence of chronic diseases and rising healthcare expenditure. Countries like China and India are emerging as lucrative markets due to their large patient populations and government support for biotechnology. Latin America presents promising growth prospects, with Brazil and Mexico investing in healthcare advancements. The Middle East & Africa region is gradually gaining traction, with countries like the UAE and South Africa recognizing the potential of biologics in improving healthcare outcomes. These emerging markets offer significant opportunities for expansion and investment in the biologics sector.

Key Trends and Drivers:

The biologics market is experiencing robust growth, fueled by advancements in biotechnology and increased demand for personalized medicine. Key trends include the rise of monoclonal antibodies and cell and gene therapies, which are revolutionizing treatment paradigms across various diseases. These innovations are driven by a deeper understanding of disease mechanisms and the human genome. Regulatory support and expedited approval pathways are further accelerating market expansion. Governments are recognizing the potential of biologics to address unmet medical needs, thus streamlining approval processes. Additionally, the increasing prevalence of chronic diseases and aging populations are significant drivers, necessitating novel therapeutic solutions. The biopharmaceutical industry is also witnessing substantial investments in research and development. Companies are focusing on enhancing production capabilities and improving drug delivery systems. Opportunities abound in emerging markets, where healthcare infrastructure is evolving. Strategic collaborations and partnerships are becoming prevalent, enabling firms to leverage complementary strengths and expand their global footprint. The biologics market is poised for sustained growth, driven by continuous innovation and strategic initiatives.

Restraints and Challenges:

The biologics market is currently encountering several significant restraints and challenges. One of the primary challenges is the high cost of biologic drugs, which limits accessibility for patients and places a financial burden on healthcare systems. The complexity of manufacturing processes for biologics further exacerbates this issue, as it requires significant investment in specialized facilities and skilled personnel. Additionally, regulatory hurdles present another formidable challenge. The stringent approval processes for biologics can lead to prolonged timelines and increased costs, discouraging smaller companies from entering the market. Intellectual property concerns also pose a significant barrier, as patent expirations open the door to biosimilars, intensifying competition and impacting market share. Supply chain disruptions, often caused by geopolitical tensions or global health crises, can lead to shortages and delays in the distribution of biologics. Lastly, the need for cold chain logistics adds another layer of complexity and cost, hindering market expansion, particularly in low-resource settings.

Key Players:

Sandoz, Samsung Biologics, Biocon, Catalent, WuXi Biologics, Lonza, Sartorius, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, Abzena, AGC Biologics, Samsung Bioepis, Cytiva, Bavarian Nordic, MorphoSys

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biologics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biologics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Material Type
  • 2.12 Key Highlights of the Market, by Deployment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Material Type
  • 3.11 Market Attractiveness Analysis, by Deployment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biologics Market Outlook

  • 4.1 Biologics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biologics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biologics Market Size

  • 6.1 Biologics Market Size, by Value
  • 6.2 Biologics Market Size, by Volume

7: Biologics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Recombinant Proteins
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Gene Therapy
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Biosimilars
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Blood Products
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Enzymes
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Biologics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Proteins
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Antibody Drug Conjugates
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cytokines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Fusion Proteins
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Growth Factors
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Hormones
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Interferons
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Interleukins
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Biologics Market, by Services

  • 9.1 Market Overview
  • 9.2 Contract Research
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Contract Manufacturing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Clinical Trials
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Quality Assurance
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Supply Chain Management
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Logistics
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Biologics Market, by Technology

  • 10.1 Market Overview
  • 10.2 DNA Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Synthetic Biology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bioprocessing
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Nanotechnology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Protein Engineering
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Bioprinting
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Biologics Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Infectious Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Autoimmune Diseases
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiovascular Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Metabolic Disorders
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Neurology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Ophthalmology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Dermatology
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region
  • 11.10 Others
    • 11.10.1 Key Market Trends & Opportunity Analysis
    • 11.10.2 Market Size and Forecast, by Region

12: Biologics Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Hospitals
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Clinics
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Diagnostic Labs
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Academic Institutions
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region
  • 12.9 Others
    • 12.9.1 Key Market Trends & Opportunity Analysis
    • 12.9.2 Market Size and Forecast, by Region

13: Biologics Market, by Process

  • 13.1 Market Overview
  • 13.2 Upstream Processing
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Downstream Processing
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Formulation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Purification
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Fermentation
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Cell Culture
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Biologics Market, by Device

  • 14.1 Market Overview
  • 14.2 Bioreactors
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Centrifuges
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Chromatography Systems
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Filtration Systems
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Mixing Systems
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Biologics Market, by Material Type

  • 15.1 Market Overview
  • 15.2 Proteins
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Antibodies
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Nucleic Acids
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Cells
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Viral Vectors
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region
  • 15.7 Others
    • 15.7.1 Key Market Trends & Opportunity Analysis
    • 15.7.2 Market Size and Forecast, by Region

16: Biologics Market, by Deployment

  • 16.1 Market Overview
  • 16.2 In-house
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Outsourced
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Hybrid
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Biologics Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Device
    • 17.2.10 North America Market Size and Forecast, by Material Type
    • 17.2.11 North America Market Size and Forecast, by Deployment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Device
      • 17.2.9.9 United States Market Size and Forecast, by Material Type
      • 17.2.9.10 United States Market Size and Forecast, by Deployment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Device
      • 17.2.10.9 Canada Market Size and Forecast, by Material Type
      • 17.2.10.10 Canada Market Size and Forecast, by Deployment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Device
    • 17.3.10 Europe Market Size and Forecast, by Material Type
    • 17.3.11 Europe Market Size and Forecast, by Deployment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Device
      • 17.3.10.9 Germany Market Size and Forecast, by Material Type
      • 17.3.10.10 Germany Market Size and Forecast, by Deployment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Device
      • 17.3.11.9 France Market Size and Forecast, by Material Type
      • 17.3.11.10 France Market Size and Forecast, by Deployment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Device
      • 17.3.12.9 Spain Market Size and Forecast, by Material Type
      • 17.3.12.10 Spain Market Size and Forecast, by Deployment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Device
      • 17.3.13.9 Italy Market Size and Forecast, by Material Type
      • 17.3.13.10 Italy Market Size and Forecast, by Deployment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Device
      • 17.3.14.9 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.10 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Device
      • 17.3.15.9 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.10 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Device
      • 17.3.16.9 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.10 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Device
      • 17.3.17.9 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.10 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Device
      • 17.3.18.9 Finland Market Size and Forecast, by Material Type
      • 17.3.18.10 Finland Market Size and Forecast, by Deployment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Device
      • 17.3.19.9 Russia Market Size and Forecast, by Material Type
      • 17.3.19.10 Russia Market Size and Forecast, by Deployment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Device
      • 17.4.9.9 China Market Size and Forecast, by Material Type
      • 17.4.9.10 China Market Size and Forecast, by Deployment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Device
      • 17.4.10.9 India Market Size and Forecast, by Material Type
      • 17.4.10.10 India Market Size and Forecast, by Deployment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Device
      • 17.4.11.9 Japan Market Size and Forecast, by Material Type
      • 17.4.11.10 Japan Market Size and Forecast, by Deployment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Device
      • 17.4.12.9 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.10 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Device
      • 17.4.13.9 Australia Market Size and Forecast, by Material Type
      • 17.4.13.10 Australia Market Size and Forecast, by Deployment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Device
      • 17.4.14.9 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.10 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Device
      • 17.4.15.9 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.10 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Device
      • 17.4.16.9 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.10 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Device
      • 17.4.17.9 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.10 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Device
    • 17.5.10 Latin America Market Size and Forecast, by Material Type
    • 17.5.11 Latin America Market Size and Forecast, by Deployment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Device
      • 17.5.9.9 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.10 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Device
      • 17.5.10.9 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.10 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Device
      • 17.5.11.9 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.10 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Device
      • 17.6.10.9 UAE Market Size and Forecast, by Material Type
      • 17.6.10.10 UAE Market Size and Forecast, by Deployment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Device
      • 17.6.11.9 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.10 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Sandoz
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Samsung Biologics
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Biocon
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Catalent
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 WuXi Biologics
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Lonza
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sartorius
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Boehringer Ingelheim
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fujifilm Diosynth Biotechnologies
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Abzena
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 AGC Biologics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Samsung Bioepis
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Cytiva
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Bavarian Nordic
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 MorphoSys
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제